Kerr Dental

• Responsible for business ownership of prescribing and referring physicians • Drive relationships and creation and execution of business plans for territories • Support product access and implement competitive response/pull-through strategies • Develop and employ customized tools and strategies to gain appropriate access to engage with HCP targets • Comfort in using sales data reporting tools to understand trends and customer insights • Continuously demonstrate deep understanding of territory market landscape, competitors, market segments/dynamics

• Develops and implements strategic and operational TAs Global Medical Affairs programs • Builds positive, effective partnerships with Medical and Commercial as well as US and Global colleagues • Drives a robust data generation program to support current indication • Co-develops strategically aligned study programs with Health Economics & Outcomes Research (HE&OR) colleagues • Leads Investigator-Initiated Trial (IIT) program • Collaborates with global team on lifecycle management studies on strategy for USA • Drives advisory boards and works closely with Field Medical on insight-gathering initiatives

• Represent the HEOR team in Medical Strategy Teams in the development of medical and HEOR strategies to demonstrate the value of products to payers, clinical decision-makers and patients. • Proactively generate and communicate evidence necessary to optimize patient access and value of Novartis products in the US market. • Exhibit medical leadership in strategic alignment with other areas and proactively propose new impactful ideas in cross-functional teams. • Manage multiple HEOR projects, associated budgets and external & internal partners, while ensuring a high level of scientific rigor and alignment with stakeholders. • Build robust external institutional and individual level partnerships as needed. • Effectively communicate impactful research to diverse audiences. • Publish and present impactful research at scientific conferences and forums. • Partner with internal stakeholders at strategic and tactical levels to shape research partnerships; generate and disseminate robust HEOR findings in support of external stakeholders including SOCs and payers. • Leverage AI tools to streamline tasks, generate content, and support decision-making, demonstrating practical fluency in prompting, interpreting, and refining AI outputs to improve work quality and efficiency.

• Identify Field Medical (FM) needs with DSC and build Neuroimmunology/Neurodegeneration disease area and scientific content strategies that differentiate Novartis products across pre-approval, launch, and lifecycle management. • Lead cross-functional planning to define FM content needs and guide Content Development, HEOR, and clinical teams to deliver high-quality, compliant scientific materials for customer engagement. • Partner with MCD and PTLs to tailor content and tools to local healthcare region needs and customer priorities. • Ensure external- and internal-facing resources stay compliant, current, and aligned to FM and disease area strategy. • Following approval, ensure content/tool availability and provide clear, compliant guidance to FM associates aligned with FM WP. • Align content and training plans with DSC, HEOR, MST, and compound timelines across disease areas and product responsibilities. • Partner with LT to align strategy, customer content, and rollout plans across the FM organization. • Shadow MSLs, capture customer insights, and continuously improve tools, content, and field effectiveness. • Develop and implement FM training plans with DSC, including scientific narrative/medical value statements, patient journey, real-world scenarios, Novartis data, disease landscape, implications, and FAQs. • Lead therapeutic onboarding, coaching, and best-practice sharing for MSLs, while driving FM plans for priority Medical Congresses, including coverage strategy, budget alignment, briefs, and deliverables.

• Provide strategic leadership for Field Insights & Analytics across the full Neuroscience and Renal portfolio • Oversee insight generation and decision support across a diverse set of in-market brands and evolving portfolio priorities • Serve as the front door to Insights & Analytics for field leaders across the Neuroscience and Renal portfolios • Engage directly with field leaders and General Managers to align insights to business priorities and support timely decision-making • Deliver proactive, integrated insights influencing portfolio, brand, and field strategy • Lead adoption and maturation of standardized Insights and Analytics frameworks anchored to enterprise and portfolio KBQs • Lead field data strategy across Neuroscience and Renal in partnership with Insights and Analytics capability teams • Lead Insights & Analytics representation across PODs and SQUADs supporting Neuroscience and Renal assets • Directly manage and develop the Associate Director focused on the Renal portfolio

• The CPM is accountable for the day-to-day planning, executing and reporting of assigned Global Drug Development studies • Responsible for assuring aligned communication with Trial Lead and other CTT members • Supports SSO Study Start-up Managers in the development of country/cluster/hub study execution plans • Proactively identifies risk and opportunities for the assigned studies within the country/cluster/hub • Maintains a strong knowledge of the study protocol to answer standard operational questions from CRAs and site personnel • Drives the conduct of the study, tracks status, maintains relevant reporting systems, oversees forecasts, progress, and mitigation plans • Ensures recruitment targets are met and reviews enrollment at the site level • Oversees local study team activities to achieve study timelines and quality execution • Conducts or coordinates training, as needed, for CRAs to support site readiness to recruit and study execution • Accountable for monitoring quality and issue resolution through timely review and approval of study monitoring visit reports

• This position can be based remotely anywhere in the U.S. (there may be some restrictions based on legal entity). • Field based, customer-facing position majority of the time with approximately 50% travel required to achieve performance and business objectives. • The Director, Value Evidence Lead (VEL) is a strategic leader who translates clinical and economic evidence into meaningful engagement across launch brands and new indications in Oncology, Cardiovascular, Renal, Immunology, and Neuroscience, with a deep understanding of US managed market dynamics. • The purpose of this role is to focus on our priority accounts to serve as the Medical Lead to proactively engage Population Health Decision Makers (PHDMs). • Engage in a variety of conversations with key stakeholders including, but not limited to, clinical data, Health Care Economic Information (HCEI), RWE, disease state information, adverse event management education and preapproval information exchange/pipeline. • Achieve agreed-upon team/personal objectives related to launch/prelaunch products, activities, and other VEL-related goals.

• Develop and execute US Medical CV pipeline and CV prevention strategies to ensure innovation, productivity, and feasibility • Ensure delivery of development activities across all compounds related to the disease area(s), with accountability for cost, time, and quality • Ensure effective team dynamics, performance, prioritization, and communication across the multidisciplinary team • Act as key point of contact with US Medical Affairs Leadership team and Global teams, and establish and maintain effective working relationships with counterparts in cross-functional and Global Line Functions and respective teams • Accountable for elaborating and establishing strategic plan activities and timelines for US Medical Affairs CV pipeline and CV prevention initiatives to enable execution according to the cross-functional strategy • Partner with external experts in disease area(s) to gain insights, inform strategic plan, and serve as primary contact between Novartis team and external stakeholders to describe strategy • Proactively identify issues and potential bottlenecks within the program, propose solutions for review by the Chief Medical Officer (CMO)/Head, US Medical Affairs, and lead risk assessment, contingency planning, and challenge program timelines and resource requirements • Lead analysis of present and future disease projections, including competitive intelligence across the pharma/biotech industry • Drive and/or coordinate development of strategy documents, risk log, and phase transition tollgates in collaboration with the team • Support the VP/Head, Medical Therapeutic Area in preparation of program recommendations and updates for governance boards

• Own end-to-end execution for assigned Therapeutic Area(s) • Serve as the single point of accountability for field execution once initiatives go live • Monitor execution health and assess field readiness as initiatives move from deployment into sustained operation • Translate execution health signals into informed decisions and corrective actions • Proactively identify risks, friction, or breakdowns and navigate timely escalation and resolution • Partner with planning, enablement, and infrastructure teams to ensure processes, tools, training, and sequencing are in place ahead of field deployment • Capture insights and lessons learned from execution to continuously strengthen FOPE standards

• Design and implement the US medical communications strategy supporting product launches, lifecycle management, and scientific engagement. • Define and execute publication strategies, including manuscripts, abstracts, posters, and scientific congress presentations. • Co-create the scientific communications platform and core scientific narratives to guide consistent, high-impact messaging. • Oversee development of scientifically accurate medical content across education programs, digital channels, symposia, MSL tools, and congresses. • Ensure consistency and alignment of medical messaging across all communication channels and materials. • Collaborate cross-functionally with Medical Affairs, Regulatory, Clinical Development, and Commercial partners across the organization. • Serve as the US Medical Affairs single point of contact to the Novartis Corporate Center for content development. • Partner with external agencies, key opinion leaders, and scientific experts to strengthen relevance and impact. • Ensure all materials meet regulatory requirements, company policies, and industry publication guidelines (e.g., GPP, ICMJE). • Lead, mentor, and develop medical writers and communication specialists, driving quality, compliance, and timely delivery.